TY - JOUR T1 - Radiotherapy in the COVID-19 Pandemic Era JF - In Vivo JO - In Vivo SP - 3731 LP - 3734 DO - 10.21873/invivo.12222 VL - 34 IS - 6 AU - ALESSANDRA GONNELLI AU - SABRINA MONTRONE AU - PAOLA COCUZZA AU - STEFANO URSINO AU - BRUNO MANFREDI AU - ROBERTO MATTIONI AU - NATALINA COCCIA AU - TAIUSHA FUENTES AU - ELISA CALISTRI AU - FRANSCESCO PASQUALETTI AU - FABIOLA PAIAR Y1 - 2020/11/01 UR - http://iv.iiarjournals.org/content/34/6/3731.abstract N2 - Background/Aim: In 2020, because of coronavirus pandemic, medical activities changed. The aim of this report is to compare the volumes of Pisa radiotherapy activities from March 9th to May 31st, 2020, with the same period in 2019. Patients and Methods: We analyzed the activity of our Unit to evaluate how logistics changes, related to the COVID-19 epidemic, impacted on volumes of radiotherapy (RT) activity and on the number of cases of COVID-19 infections observed in healthcare professionals and patients. Results: The total number of first-time visits between March-May 2020 was reduced by 18%, probably due to delays in diagnosis and histological tests as well as the temporary closure of the operating rooms. None of the healthcare professionals and only two patients contracted the infection. Conclusion: We were able to treat all patients referred to our hospital and we were able to reduce risk of infection for both our patients and healthcare staff, guaranteeing continuum of care for our oncological patients. ER -